Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Memorial Sloan Kettering Cancer Center, Inserm, Université de Montpellier, Université Paris Cité, Institut de Recherche en Cancérologie de Montpellier, Kanagawa Prefectural Hospital Organization, Kanagawa Cancer Center, University Health System, Yonsei University Health System, Hospital Clínic de Barcelona, National Hospital Organization Kyushu Cancer Center, Showa University Hospital, The University of Texas MD Anderson Cancer Center, Target (United States), Breast Cancer Research Foundation, Universitat de Barcelona, Kyungpook National University Hospital, National Cancer Center, Tokai University, Samsung Medical Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Zhejiang Cancer Hospital, Institut Català d'Oncologia, Duran i Reynals Hospital, Jilin University, First Hospital of Jilin University, Institut Curie, New Generation University College, Seoul National University Hospital, National University College, Cleveland Clinic, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Tel Aviv University, Rabin Medical Center, Alexandra Hospital, Institut Jules Bordet, Ulsan College, Asan Medical Center, University of Ulsan, Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Sichuan University, West China Hospital of Sichuan University, Hebron University, Vall d'Hebron Institute of Oncology, Queen Mary University of London, Liaoning Cancer Hospital & Institute, Daiichi Sankyo (United States), Ludwig-Maximilians-Universität München, Edinburgh Cancer Research